Neoadjuvant PD-1 inhibitor combines with chemotherapy versus neoadjuvant chemotherapy in resectable squamous cell carcinoma of the lung.
Yuan FengWei SunJie ZhangYang WangJinfeng ChenXinying LiuLiang WangShaolei LiChao LvFangliang LuJianzhi ZhangYang HongShanshan XiaoTao WangRaymond JiaoZiping WangLiping QiNan LiYue YangDongmei LinJian FangPublished in: Thoracic cancer (2021)
The combination of neoadjuvant chemotherapy and PD-1 blockade is safe and feasible, and might indicate an increased MPR and pathological complete response rate. More investigations are needed for the best combination of the neoadjuvant therapy.